|
Research & Development
|
28.00M | 60.94M |
|
Selling, General & Administrative
|
8.18M | 22.12M |
|
Operating Expenses
|
36.18M | 83.06M |
|
Operating Income
|
-36.18M | -83.06M |
|
EBIT
|
-36.18M | -83.06M |
|
Interest & Investment Income
|
2.53M | 12.14M |
|
Non Operating Income
|
1.40M | 4.75M |
|
EBT
|
-34.78M | -78.31M |
|
Tax Provisions
|
0.01M | |
|
Profit After Tax
|
-34.80M | -78.31M |
|
Income from Continuing Operations
|
-34.79M | -78.31M |
|
Consolidated Net Income
|
-34.79M | -78.31M |
|
Income towards Parent Company
|
-34.79M | -78.31M |
|
Net Income towards Common Stockholders
|
-34.79M | -78.31M |
|
EPS (Basic)
|
-0.00M | -0.00M |
|
EPS (Weighted Average and Diluted)
|
-0.00M | -0.00M |
|
Shares Outstanding (Weighted Average)
|
27.38M | 36.58M |
|
EBITDA
|
-34.78M | -78.83M |